{"paper_id":"cb384b62-20f0-4e00-b9b6-97aeda9a75dd","body_text":"Abstract\nChronic abdomino-pelvic pain or chronic pelvic pain (CPP) is estimated to affect 4 % of women, decreasing quality of life and work productivity, with healthcare costs of more than two billion dollars per year in the United States. Diagnosis of the etiology is difficult as symptoms can be vague and often the patient has several sources for her pain. Non-gynecologic disorders are associated with higher prevalence rates than gynecologic disorders and include: Irritable bowel syndrome (IBS), interstitial cystitis/painful bladder syndrome (IC/PBS), abdominal/pelvic myofascial pain, and neuralgias (discussed in other chapters of this book). Gynecologic disorders include: endometriosis, prior pelvic inflammatory disease, leiomyomata, adenomyosis, tuberculous salpingitis, ovarian remnant syndrome, ovarian retention syndrome, and pelvic congestion syndrome. Dysmenorrhea (pain with the menstrual cycle) and dyspareunia (pain with sexual intercourse) are also common symptoms. Other non-gynecologic disorders, such as depression, fibromyalgia, migraines, low back pain, or a history of physical/sexual abuse, should be evaluated and addressed. Patients with CPP often have been to multiple doctors and had numerous interventions without any improvement of pain or even a diagnosis. A patient–physician relationship based on empathy and trust, along with patient education and setting realistic goals (including pain decrease with improvement of daily functioning), is extremely important.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nZondervan KT, Yudkin PL, Vessey MP, Dawes MG, Barlow DH, Kennedy SH. Prevalence and incidence of chronic pelvic pain in primary care: evidence from a national general practice database. Br J Obstet Gynaecol. 1999;106(11):1149–55.\nLippman SA, Warner M, Samuels S, Olive D, Vercellini P, Eskenazi B. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril. 2003;80(6):1488–94.\nMathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–7.\nHillis SD, Marchbanks PA, Peterson HB. The effectiveness of hysterectomy for chronic pelvic pain. Obstet Gynecol. 1995;86(6):941–5.\nHoward FM. The role of laparoscopy in chronic pelvic pain: promise and pitfalls. Obstet Gynecol Surv. 1993;48(6):357–87.\nACOG Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet Gynecol. 2004;103(3):589–605.\nHoward FM. Chronic pelvic pain. Obstet Gynecol. 2003;101(3):594–611.\nZondervan KT, Yudkin PL, Vessey MP, et al. Chronic pelvic pain in the community—symptoms, investigations, and diagnoses. Am J Obstet Gynecol. 2001;184(6):1149–55.\nTracey I, Bushnell MC. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain. 2009;10(11):1113–20.\nDroz J, Howard FM. Use of the short-form McGill Pain Questionnaire as a diagnostic tool in women with chronic pelvic pain. J Minim Invasive Gynecol. 2011;18(2):211–7.\nElzevier HW, Voorham-van der Zalm PJ, Pelger RC. How reliable is a self-administered questionnaire in detecting sexual abuse: a retrospective study in patients with pelvic-floor complaints and a review of literature. J Sex Med. 2007;4(4 Pt 1):956–63.\nWijma B, Schei B, Swahnberg K, et al. Emotional, physical, and sexual abuse in patients visiting gynaecology clinics: a Nordic cross-sectional study. Lancet. 2003;361(9375):2107–13.\nLamvu G, Williams R, Zolnoun D, et al. Long-term outcomes after surgical and nonsurgical management of chronic pelvic pain: one year after evaluation in a pelvic pain specialty clinic. Am J Obstet Gynecol. 2006;195(2):591–8; discussion 598–600.\nGiamberardino MA, De Laurentis S, Affaitati G, Lerza R, Lapenna D, Vecchiet L. Modulation of pain and hyperalgesia from the urinary tract by algogenic conditions of the reproductive organs in women. Neurosci Lett. 2001;304(1–2):61–4.\nBerkley KJ, Cason A, Jacobs H, Bradshaw H, Wood E. Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett. 2001;306(3):185–8.\nChung MK, Chung RR, Gordon D, Jennings C. The evil twins of chronic pelvic pain syndrome: endometriosis and interstitial cystitis. JSLS. 2002;6(4):311–4.\nStratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327–46.\nGuo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607.\nAdamson GD. Diagnosis and clinical presentation of endometriosis. Am J Obstet Gynecol. 1990;162(2):568–9.\nSutton C, Hill D. Laser laparoscopy in the treatment of endometriosis. A 5-year study. Br J Obstet Gynaecol. 1990;97(2):181–5.\nWalter AJ, Hentz JG, Magtibay PM, Cornella JL, Magrina JF. Endometriosis: correlation between histologic and visual findings at laparoscopy. Am J Obstet Gynecol. 2001;184(7):1407–11; discussion 1411–3.\nMartin DC, Hubert GD, Vander Zwaag R, el-Zeky FA. Laparoscopic appearances of peritoneal endometriosis. Fertil Steril. 1989;51(1):63–7.\nJansen RP, Russell P. Nonpigmented endometriosis: clinical, laparoscopic, and pathologic definition. Am J Obstet Gynecol. 1986;155(6):1154–9.\nLing FW. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol. 1999;93(1):51–8.\nHornstein MD, Yuzpe AA, Burry K, et al. Retreatment with nafarelin for recurrent endometriosis symptoms: efficacy, safety, and bone mineral density. Fertil Steril. 1997;67(6):1013–8.\nHornstein MD, Surrey ES, Weisberg GW, Casino LA. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group. Obstet Gynecol. 1998;91(1):16–24.\nFarquhar C, Sutton C. The evidence for the management of endometriosis. Curr Opin Obstet Gynecol. 1998;10(4):321–32.\nTelimaa S, Puolakka J, Ronnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol. 1987;1(1):13–23.\nSchlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril. 2006;85(2):314–25.\nVercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60(1):75–9.\nVercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril. 2003;80(3):560–3.\nPetta CA, Ferriani RA, Abrao MS, et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod. 2005;20(7):1993–8.\nMousa NA, Bedaiwy MA, Casper RF. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol. 2007;109(6):1421–3.\nNawathe A, Patwardhan S, Yates D, Harrison GR, Khan KS. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG. 2008;115(7):818–22.\nChwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev. 2005;26(3):423–38.\nVercellini P, Pietropaolo G, De Giorgi O, Pasin R, Chiodini A, Crosignani PG. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril. 2005;84(5):1375–87.\nSutton CJ, Ewen SP, Whitelaw N, Haines P. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994;62(4):696–700.\nAbbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004;82(4):878–84.\nParazzini F, Fedele L, Busacca M, et al. Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial. Am J Obstet Gynecol. 1994;171(5):1205–7.\nHornstein MD, Hemmings R, Yuzpe AA, Heinrichs WL. Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis. Fertil Steril. 1997;68(5):860–4.\nCandiani GB, Fedele L, Vercellini P, Bianchi S, Di Nola G. Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: a controlled study. Am J Obstet Gynecol. 1992;167(1):100–3.\nZullo F, Palomba S, Zupi E, et al. Effectiveness of presacral neurectomy in women with severe dysmenorrhea caused by endometriosis who were treated with laparoscopic conservative surgery: a 1-year prospective randomized double-blind controlled trial. Am J Obstet Gynecol. 2003;189(1):5–10.\nZullo F, Palomba S, Zupi E, et al. Long-term effectiveness of presacral neurectomy for the treatment of severe dysmenorrhea due to endometriosis. J Am Assoc Gynecol Laparosc. 2004;11(1):23–8.\nVercellini P, Aimi G, Busacca M, Apolone G, Uglietti A, Crosignani PG. Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fertil Steril. 2003;80(2):310–9.\nNamnoum AB, Hickman TN, Goodman SB, Gehlbach DL, Rock JA. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995;64(5):898–902.\nMetzger DA, Lessey BA, Soper JT, McCarty Jr KS, Haney AF. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content. Obstet Gynecol. 1991;78(5 Pt 2):946–50.\nRedwine DB. Endometriosis persisting after castration: clinical characteristics and results of surgical management. Obstet Gynecol. 1994;83(3):405–13.\nDmowski WP, Radwanska E, Rana N. Recurrent endometriosis following hysterectomy and oophorectomy: the role of residual ovarian fragments. Int J Gynaecol Obstet. 1988;26(1):93–103.\nPerry CP. Current concepts of pelvic congestion and chronic pelvic pain. JSLS. 2001;5(2):105–10.\nCreton D, Hennequin L, Kohler F, Allaert FA. Embolisation of symptomatic pelvic veins in women presenting with non-saphenous varicose veins of pelvic origin—three-year follow-up. Eur J Vasc Endovasc Surg. 2007;34(1):112–7.\nHaggerty CL, Peipert JF, Weitzen S, et al. Predictors of chronic pelvic pain in an urban population of women with symptoms and signs of pelvic inflammatory disease. Sex Transm Dis. 2005;32(5):293–9.\nTrent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis. 2011;38(9):879–81.\nSwank DJ, Swank-Bordewijk SC, Hop WC, et al. Laparoscopic adhesiolysis in patients with chronic abdominal pain: a blinded randomised controlled multi-centre trial. Lancet. 2003;361(9365):1247–51.\nPeters AA, Trimbos-Kemper GC, Admiraal C, Trimbos JB, Hermans J. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynaecol. 1992;99(1):59–62.\nMatalliotakis IM, Katsikis IK, Panidis DK. Adenomyosis: what is the impact on fertility? Curr Opin Obstet Gynecol. 2005;17(3):261–4.\nDietrich JE. An update on adenomyosis in the adolescent. Curr Opin Obstet Gynecol. 2010;22(5):388–92.\nPopovic M, Puchner S, Berzaczy D, Lammer J, Bucek RA. Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol. 2011;22(7):901–9; quiz 909.\nCramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–8.\nChavez NF, Stewart EA. Medical treatment of uterine fibroids. Clin Obstet Gynecol. 2001;44(2):372–84.\nSalman T, Davis C. Uterine fibroids, management and effect on fertility. Curr Opin Obstet Gynecol. 2010;22(4):295–303.\nAmerican College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112(2 Pt 1):387–400.\nGoodwin SC, Spies JB. Uterine fibroid embolization. N Engl J Med. 2009;361(7):690–7.\nFoster DC. Vulvar disease. Obstet Gynecol. 2002;100(1):145–63.\nEdwards L. New concepts in vulvodynia. Am J Obstet Gynecol. 2003;189(3 Suppl):S24–30.\nFoster DC, Kotok MB, Huang LS, et al. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116(3):583–93.\nBergeron S, Binik YM, Khalife S, et al. A randomized comparison of group cognitive—behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91(3):297–306.\nBergeron S, Khalife S, Glazer HI, Binik YM. Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome. Obstet Gynecol. 2008;111(1):159–66.\nLavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin. 2007;25(4):841–51. vii–iii.\nLavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Med Clin North Am. 2007;91(2):229–39.\nHoffman D. Understanding multisymptom presentations in chronic pelvic pain: the inter-relationships between the viscera and myofascial pelvic floor dysfunction. Curr Pain Headache Rep. 2011;15(5):343–6.\nLabat JJ, Riant T, Robert R, Amarenco G, Lefaucheur JP, Rigaud J. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn. 2008;27(4):306–10.\nHibner M, Desai N, Robertson LJ, Nour M. Pudendal neuralgia. J Minim Invasive Gynecol. 2010;17(2):148–53.\nRobert R, Labat JJ, Bensignor M, et al. Decompression and transposition of the pudendal nerve in pudendal neuralgia: a randomized controlled trial and long-term evaluation. Eur Urol. 2005;47(3):403–8.\nSteege JF. Ovarian remnant syndrome. Obstet Gynecol. 1987;70(1):64–7.\nNezhat C, Kearney S, Malik S, Nezhat F. Laparoscopic management of ovarian remnant. Fertil Steril. 2005;83(4):973–8.\nSiddall-Allum J, Rae T, Rogers V, Witherow R, Flanagan A, Beard RW. Chronic pelvic pain caused by residual ovaries and ovarian remnants. Br J Obstet Gynaecol. 1994;101(11):979–85.\nEl-Minawi AM, Howard FM. Operative laparoscopic treatment of ovarian retention syndrome. J Am Assoc Gynecol Laparosc. 1999;6(3):297–302.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2015 Springer Science+Business Media New York\nAbout this chapter\nCite this chapter\nYamamoto, M.P., Carillo, J.F., Howard, F.M. (2015). Chronic Abdominal Pain of Gynecologic Causes: Diagnosis and Treatment. In: Kapural, L. (eds) Chronic Abdominal Pain. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1992-5_10\nDownload citation\nDOI: https://doi.org/10.1007/978-1-4939-1992-5_10\nPublished:\nPublisher Name: Springer, New York, NY\nPrint ISBN: 978-1-4939-1991-8\nOnline ISBN: 978-1-4939-1992-5\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}